Cargando…

Impact of Obesity on Ceftriaxone Efficacy †

Background: Ceftriaxone has standard, set dosing regimens that may not achieve adequate serum concentrations in obese patients compared to non-obese patients. The purpose of this study was to evaluate the effect of obesity on ceftriaxone efficacy when used as definitive monotherapy to treat infectio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barber, Katie E., Loper, J. Taylor, Morrison, Austin R., Stover, Kayla R., Wagner, Jamie L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563366/ https://www.ncbi.nlm.nih.gov/pubmed/32660113 http://dx.doi.org/10.3390/diseases8030027

Ejemplares similares

1381. Impact of Total Body Weight on Efficacy of Ceftriaxone in Obese Patients
por: Wagner, Jamie L, et al.
Publicado: (2018)

1380. Effect of Absolute Body Weight on Clinical Outcomes of Obese Patients Treated with Cefepime
por: Wagner, Jamie L, et al.
Publicado: (2018)

Ceftriaxone for the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Case Series
por: Lowe, Rachel Amanda, et al.
Publicado: (2017)

Impact of Obesity on Acyclovir-Induced Nephrotoxicity
por: Barber, Katie E, et al.
Publicado: (2019)

Ceftriaxone as an Alternative Therapy for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia after Initial Clearance of Bloodstream Infection
por: Barber, Katie E., et al.
Publicado: (2021)

366. Impact of Obesity in Patients With Candida Bloodstream Infections
por: Barber, Katie E, et al.
Publicado: (2018)

Impact of Obesity in Patients with Candida Bloodstream Infections: A Retrospective Cohort Study
por: Barber, Katie E., et al.
Publicado: (2020)

Impact of piperacillin-tazobactam shortage on meropenem use: implications for antimicrobial stewardship programs
por: Barber, Katie E., et al.
Publicado: (2016)

Effect of Obesity on Clinical Failure of Patients Treated With β-Lactams
por: Pinner, Nathan A, et al.
Publicado: (2021)

Allergic Reactions and Cross-Reactivity Potential with Beta-Lactamase Inhibitors
por: Stover, Kayla R., et al.
Publicado: (2019)

Enolase Is Implicated in the Emergence of Gonococcal Tolerance to Ceftriaxone
por: Manoharan-Basil, Sheeba Santhini, et al.
Publicado: (2023)

Time–Kill Analysis of Ceftolozane/Tazobactam Efficacy Against Mucoid Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients
por: Rac, Hana, et al.
Publicado: (2017)

Fluoroquinolone Versus Nonfluoroquinolone Treatment of Bloodstream Infections Caused by Chromosomally Mediated AmpC-Producing Enterobacteriaceae
por: Gunter, Sarah Grace, et al.
Publicado: (2020)

Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis C
por: Bell, Allison M., et al.
Publicado: (2016)

Intravenous Vancomycin Dosing in the Elderly: A Focus on Clinical Issues and Practical Application
por: Barber, Katie E., et al.
Publicado: (2016)

In vitro study of synergy of ampicillin with ceftriaxone against Listeria monocytogenes
por: Lepe, José Antonio, et al.
Publicado: (2019)

597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors
por: Wingler, Mary Joyce B, et al.
Publicado: (2018)

Analysis of the Clinical Impact of the BioFire FilmArray Meningitis Encephalitis Panel on Antimicrobial Use and Duration of Therapy at an Academic Medical Center
por: Markovich, Kylie, et al.
Publicado: (2022)

Ceftriaxone: Lack of efficacy: case report
Publicado: (2022)

Ceftriaxone for the Treatment of Chronic Bacterial Prostatitis: A Case Series and Literature Review
por: Kuiper, Sander G., et al.
Publicado: (2022)

A clinical and in vitro assessment of outpatient parenteral benzylpenicillin and ceftriaxone combination therapy for enterococcal endovascular infections
por: Ingram, Paul R, et al.
Publicado: (2021)

Switching From Ceftriaxone to Cefotaxime Significantly Contributes to Reducing the Burden of Clostridioides difficile infections
por: Wendt, Sebastian, et al.
Publicado: (2020)

Dalbavancin Use for the Treatment of Methicillin-resistant Staphylococcus aureus Pneumonia
por: Barber, Katie E., et al.
Publicado: (2017)

Omadacycline Enters the Ring: A New Antimicrobial Contender
por: Barber, Katie E., et al.
Publicado: (2018)

Cephalosporin Side Chain Idiosyncrasies: A Case Report of Ceftriaxone-Induced Agranulocytosis and Review of Literature
por: Uy, Natalie, et al.
Publicado: (2015)

Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant Enterococci
por: Wingler, Mary Joyce, et al.
Publicado: (2021)

Ceftriaxone/dopamine/vancomycin: Lack of efficacy: case report
Publicado: (2021)

1512. Treatment of Staphylococcus aureus Bacteremia in a Pediatric Population: A Retrospective Cohort Analysis
por: Gunter, Sarah G, et al.
Publicado: (2019)

An evaluation of antipseudomonal dosing on the incidence of treatment failure
por: Hawkins, Brandon K, et al.
Publicado: (2021)

Intravenous versus Oral Step-Down for the Treatment of Staphylococcus aureus Bacteremia in a Pediatric Population
por: Gunter, Sarah Grace, et al.
Publicado: (2022)

The In Vitro Efficacy of Activated Charcoal in Fecal Ceftriaxone Adsorption among Patients Who Received Intravenous Ceftriaxone
por: Torvorapanit, Pattama, et al.
Publicado: (2023)

2527. Impact of Hypoalbuminemia on Clinical Outcomes Among Patients with Obesity Treated with Ceftriaxone
por: Rivera (O'Connor), Christina G, et al.
Publicado: (2023)

Hospital Admission Patterns in Adult Patients with Community-Acquired Pneumonia Who Received Ceftriaxone and a Macrolide by Disease Severity across United States Hospitals
por: Lodise, Thomas P., et al.
Publicado: (2020)

Identification of ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone and isolates harboring a novel mosaic penA gene in Chengdu in 2019–2020
por: Wang, Di, et al.
Publicado: (2023)

Asymptomatic ceftriaxone‐associated pseudolithiasis
por: Sasaki, Osamu, et al.
Publicado: (2019)

Ceftriaxone: Agranulocytosis: case report
Publicado: (2021)

Ceftriaxone-induced Acute Cholecystitis
por: Gomes, Fernanda Marta, et al.
Publicado: (2021)

Ceftriaxone/hydroxychloroquine/lopinavir: Lack of efficacy in off-label use: case report
Publicado: (2021)

Ceftriaxone/favipiravir/vancomycin: Lack of efficacy and off-label use: case report
Publicado: (2022)

Impact of obesity on childhood kidney
por: Kaneko, Kazunari, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4n9bp31b8av7huvj3uerrh2f2l